POLY MEDICURE LTD.
BSE: 531768
Revenue & Profit Trend
in croresMargin Trend
percentage| Period | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 431.10-2.7% | 443.01+5.8% | 418.86+0.6% | 416.54+8.5% | 384.05-8.8% | 420.97+2.4% | 410.94+2.1% | 402.47 |
| Other Income | 28.65+89.5% | 15.12-48.8% | 29.55-12.4% | 33.72-17.9% | 41.10+71.6% | 23.95+10.1% | 21.75-20.2% | 27.25 |
| Total Income | 459.75+0.4% | 458.14+2.2% | 448.41-0.4% | 450.26+5.9% | 425.14-4.4% | 444.92+2.8% | 432.69+0.7% | 429.71 |
| EXPENSES | ||||||||
| Expenditure | 341.11-2.9% | 351.33+4.7% | 335.59+1.0% | 332.26+7.8% | 308.08-6.2% | 328.42+2.9% | 319.30+2.1% | 312.78 |
| Tax | 30.52+16.5% | 26.18-5.2% | 27.63-4.6% | 28.96-0.6% | 29.14-2.3% | 29.84+5.7% | 28.24-5.0% | 29.71 |
| PROFIT | ||||||||
| PBT | 118.64+11.1% | 106.81+0.7% | 106.01-10.2% | 118.01+0.8% | 117.06+0.5% | 116.50+2.7% | 113.39-3.0% | 116.93 |
| Net Profit | 88.12+9.3% | 80.62+2.9% | 78.38-12.0% | 89.05+1.3% | 87.93+1.5% | 86.66+1.8% | 85.15-2.4% | 87.22 |
| KEY METRICS | ||||||||
| OPM % | 28.03%+0.70pp | 27.33%+2.15pp | 25.18%-1.52pp | 26.70%+0.24pp | 26.46%-1.11pp | 27.57%+11.10pp | 16.47%-0.04pp | 16.51% |
| NPM % | 19.17%+1.57pp | 17.60%+0.12pp | 17.48%-2.30pp | 19.78%-0.90pp | 20.68%+1.20pp | 19.48%-0.20pp | 19.68%-0.62pp | 20.30% |
| EPS | 8.69+9.3% | 7.95+2.8% | 7.73-12.1% | 8.79+1.3% | 8.68+3.3% | 8.40-0.9% | 8.48-5.7% | 8.99 |
Corporate Events
Board Meeting
The 31st Annual General Meeting of the Company is scheduled …
BSE Filing ↗Board Meeting
The company informs that a one-on-one meeting with Wasatch G…
BSE Filing ↗Board Meeting
The Board Meeting is scheduled to consider and approve the U…
BSE Filing ↗Board Meeting
Company officials will hold one-on-one meetings with analyst…
BSE Filing ↗Board Meeting
An investor meeting scheduled for May 27, 2026, has been can…
BSE Filing ↗Board Meeting
Consider and approve Unaudited Financial Results, Transact o…
BSE Filing ↗Board Meeting
The 31st Annual General Meeting of the Company is scheduled …
BSE Filing ↗Board Meeting
Consider and approve the Unaudited Financial Results (Consol…
BSE Filing ↗Board Meeting
Consider and finalize the terms and condition and approve th…
BSE Filing ↗Board Meeting
Consider and approve Standalone and Consolidated Un-audited …
BSE Filing ↗Board Meeting
Consider and approve Standalone and Consolidated Un-audited …
BSE Filing ↗